Zhao Jianyi, Cheng Lilin, Yang Jian, Xu Feifei, Qi Weixiang, Liao Keman, Zhou Li, Cao Lu, Chen Jiayi, Lin Yingying
Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China; Shanghai Key Laboratory of Proton-Therapy, Shanghai, 201801, China.
Department of Neurosurgery, Changhai Hospital, Naval Medical University, Shanghai, 200433, China.
Cancer Lett. 2025 Mar 1;612:217483. doi: 10.1016/j.canlet.2025.217483. Epub 2025 Jan 20.
Tumor-nerve interactions play a critical role in tumor progression, metastasis, and treatment resistance, redefining our understanding of the tumor microenvironment. This review provides a comprehensive analysis of how the peripheral and central nervous systems contribute to cancer biology, focusing on mechanisms of neural invasion, immune evasion, and tumor adaptation. It has highlighted the emerging potential of repurposing nervous system-targeted drugs originally developed for neurodegenerative and autoimmune diseases as innovative cancer therapies. The review also addresses key challenges, including the limitations of current experimental models and the complexity of translating preclinical findings to clinical applications. By bridging the gap between neuroscience and oncology, this interdisciplinary study aims to discover novel therapeutic strategies to improve outcomes for cancer patients.
肿瘤与神经的相互作用在肿瘤进展、转移和治疗耐药性中起着关键作用,重新定义了我们对肿瘤微环境的理解。本综述全面分析了外周和中枢神经系统如何影响癌症生物学,重点关注神经侵袭、免疫逃逸和肿瘤适应机制。它强调了将最初开发用于神经退行性疾病和自身免疫性疾病的靶向神经系统药物重新用作创新癌症疗法的新潜力。该综述还探讨了关键挑战,包括当前实验模型的局限性以及将临床前研究结果转化为临床应用的复杂性。通过弥合神经科学与肿瘤学之间的差距,这项跨学科研究旨在发现新的治疗策略,以改善癌症患者的治疗效果。